Repository logo
 
Loading...
Thumbnail Image
Publication

Undetectable Levels of CSF Amyloid-β Peptide in a Patient with 17β-Hydroxysteroid Dehydrogenase Deficiency

Use this identifier to reference this record.
Name:Description:Size:Format: 
J Alzheimer Dis 2011_27_253.pdf262.39 KBAdobe PDF Download

Advisor(s)

Abstract(s)

17β-hydroxysteroid dehydrogenase 10 (HSD10) deficiency is a rare X-linked inborn error of isoleucine catabolism. Although this protein has been genetically implicated in Alzheimer's disease pathogenesis, studies of amyloid-β peptide (Aβ) in patients with HSD10 deficiency have not been previously reported. We found, in a severely affected child with HSD10 deficiency, undetectable levels of Aβ in the cerebrospinal fluid, together with low expression of brain-derived neurotrophic factor, α-synuclein, and serotonin metabolites. Confirmation of these findings in other patients would help elucidating mechanisms of synaptic dysfunction in this disease, and highlight the role of Aβ in both early and late periods of life.

Description

Keywords

17-Hydroxysteroid Dehydrogenases Amyloid beta-Peptides Biomarkers Brain Diseases, Metabolic, Inborn Child, Preschool Fatal Outcome Genes, X-Linked Humans Male HDE NEU PED

Pedagogical Context

Citation

J Alzheimers Dis. 2011;27(2):253-7

Research Projects

Organizational Units

Journal Issue

Publisher

IOS Press

CC License

Altmetrics